The variant **rs121913529** is located in the **FGFR3** gene, which encodes the fibroblast growth factor receptor 3. This gene is associated with several skeletal dysplasia conditions, including achondroplasia and hypochondroplasia. Missense variants in the FGFR3 gene are well-documented and are often pathogenic due to their impact on receptor function.

Here are some notable missense variants in the FGFR3 gene:

1. **rs28931614 (p.Gly380Arg)**  
   - Associated with achondroplasia, the most common form of dwarfism.  
   - This variant leads to constitutive activation of the FGFR3 receptor.

2. **rs121913507 (p.Asn540Lys)**  
   - Associated with hypochondroplasia, a milder skeletal dysplasia compared to achondroplasia.  
   - Causes increased receptor activity but less severe than p.Gly380Arg.

3. **rs121913501 (p.Arg248Cys)**  
   - Associated with thanatophoric dysplasia type I, a lethal skeletal disorder.  
   - This variant results in abnormal receptor dimerization and activation.

4. **rs121913502 (p.Ser249Cys)**  
   - Also associated with thanatophoric dysplasia type I.  
   - Similar pathogenic mechanism as p.Arg248Cys.

5. **rs121913504 (p.Lys650Glu)**  
   - Associated with thanatophoric dysplasia type II.  
   - Causes severe constitutive activation of FGFR3.

6. **rs121913505 (p.Lys650Met)**  
   - Associated with SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans).  
   - Leads to receptor hyperactivation.

These variants are examples of how missense mutations in FGFR3 can lead to a spectrum of disorders, depending on the specific amino acid change and its impact on receptor function.

---

**日本語:**
**rs121913529**は**FGFR3**遺伝子に位置する変異で、この遺伝子は線維芽細胞増殖因子受容体3をコードしています。FGFR3遺伝子のミスセンス変異は、軟骨無形成症や低軟骨形成症などの骨異形成症に関連しています。

以下はFGFR3遺伝子における主なミスセンス変異の例です：

1. **rs28931614 (p.Gly380Arg)**  
   - 軟骨無形成症に関連する、最も一般的な変異。  
   - 受容体の恒常的な活性化を引き起こします。

2. **rs121913507 (p.Asn540Lys)**  
   - 低軟骨形成症に関連する、軟骨無形成症より軽度の骨異形成症。  
   - 受容体活性が増加しますが、p.Gly380Argほど重症ではありません。

3. **rs121913501 (p.Arg248Cys)**  
   - 致死性骨異形成症であるタナトフォリック骨異形成症I型に関連。  
   - 異常な受容体二量体化と活性化を引き起こします。

4. **rs121913502 (p.Ser249Cys)**  
   - 同じくタナトフォリック骨異形成症I型に関連。  
   - p.Arg248Cysと同様の病的メカニズム。

5. **rs121913504 (p.Lys650Glu)**  
   - タナトフォリック骨異形成症II型に関連。  
   - FGFR3の重度の恒常的活性化を引き起こします。

6. **rs121913505 (p.Lys650Met)**  
   - SADDAN（重度軟骨無形成症、発達遅延、黒色表皮腫）に関連。  
   - 受容体の過剰活性化を引き起こします。

これらの変異は、特定のアミノ酸変化とその受容体機能への影響に応じて、FGFR3遺伝子の変異が疾患のスペクトラムを引き起こす例です。